What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Slanix Paul Alex: large open-market buy of PMN
$8.5M open-market purchase by Slanix Paul Alex, Director at ProMIS Neurosciences Inc, filed February 6, 2026. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View PMN
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Insider purchase
Slanix Paul Alex bought $8.5M of PMN
Slanix Paul Alex, a Director, reported a $8.5M open-market purchase equal to 8.6% of PMN's market cap.
Slanix Paul Alex (Director) bought 700,741 shares of PMN, ProMIS Neurosciences Inc, Healthcare ($99.1M market cap), at $12.13 per share on February 3, 2026 for a total of $8.5M (8.6% of the market cap).
- % of market cap
- 8.6%
- Purchase value
- $8.5M
- Shares purchased
- 700,741
- Price per share
- $12.13 per share
- Trade date
- February 3, 2026
- Filed
- February 6, 2026
- Filing delay
- 3 days
Permalink https://bluecollarpicks.com/insider-trading/PMN/buy/2068904
Market context
PMN market snapshot
Last enriched May 6, 2026 at 9:01 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning.
| Ticker | Type & Role | Value | Filed |
|---|---|---|---|
Buy Director | $45.3K | ||
Buy Director | $48.8K | ||
Buy Director | $48K | ||
Buy Director | $21.9K | ||
Buy Director | $22.5K | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Buy Officer | $25K | ||
Grant Director | $50K | ||
Grant Director | $0 | ||
Grant Officer | $25K | ||
Grant Officer | $0 | ||
Grant CEO | $75K | ||
Grant CEO | $0 | ||
Grant Officer | $80K | ||
Grant Officer | $0 | ||
Grant Director | $37K | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Grant Director | $0 | ||
Buy 10% Owner | Not reported | ||
| This filing | Big Buy Director | $8.5M | |
Buy Director | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy Officer | $14.9K | ||
Buy Director | $14.6K | ||
$45.3K
Buy Director
$48.8K
Buy Director
$48K
Buy Director
$21.9K
Buy Director
$22.5K
Buy Director
$25K
Buy Officer
$50K
Grant Director
$0
Grant Director
$25K
Grant Officer
Grant Officer
$75K
Grant CEO
$0
Grant CEO
$80K
Grant Officer
$0
Grant Officer
$37K
Grant Director
Grant Director
Not reported
Buy 10% Owner
$8.5M
Big Buy Director
Not reported
Buy Director
Not reported
Buy 10% Owner
Not reported
Buy 10% Owner
$14.9K
Buy Officer
$14.6K
Buy Director
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method
Public data, presented plainly
Named views
Ready-made views give you a clear starting point before you touch filters.
Cluster logic
Cluster buys mean multiple insiders buying the same ticker inside a short window.
Normalized rows
Rows preserve filing date, trade date, role, value, and source links where available.
All data remains available
Filtered rows are not hidden. Grants, exercises, tax withholding, gifts, and conversions stay available in All Form 4 Filings, ticker history, and specialized views.
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.